CClinicalTrials.gg
CompletedNCT02701920HeartLightUpdated May 17, 2018

HeartLight: Heart Rate Monitoring for Newborn Resuscitation

An observational study in Infant, Newborn, Diseases, Fetus or Neonate Affected by Cesarean Section and Infant, Premature, Diseases, sponsored by University of Nottingham. Completed at 1 site in United Kingdom. Open to participants aged Up to 4 Months. Per ClinicalTrials.gov, last updated 2018-05-17.

Sponsored by University of Nottingham · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
184
Ages
Up to 4 Months
Sex
All
01

Study summary

This study will compare a newborn heart rate sensor (HeartLight) that is integrated into a hat with other common forms of heart rate monitoring such as electrocardiography (ECG), stethoscope and pulse oximetry (PO) in newborn babies. This will help to evaluate the new heart rate sensor's reliability and accuracy.

Read the detailed description

Up to 10% of newborns require some form of resuscitation at birth. Heart rate (HR) is the most sensitive indicator of resuscitation efficacy. HR is most commonly estimated using a stethoscope. However, in simulation studies it has been shown that newborn healthcare providers estimate HR incorrectly in up to 1/3 of cases. Common techniques for monitoring heart rate such as electrocardiography (ECG) and pulse oximetry (PO) were not developed for resuscitation at birth.

ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. The usual site for transmission PO is the foot or hand. However, in newborn babies, and particularly those requiring resuscitation when the HR is low, blood flow is reduced so physiological mechanisms preserve brain and heart blood flow at the expense of other less important organs and limbs. As a consequence of this and the choice of wavelengths, it can be more difficult to obtain a reliable HR from POs on the limbs, and they typically obtain an HR after 1-2 minutes.

In the delivery room, ECG and PO systems have a requirement for cables to connect to the main monitors. These can get in the way and it is now recommended for many babies to delay cutting the umbilical cord (to ensure more blood enters the baby from the placenta) which often requires the baby to be resuscitated very close to the mother and even between their legs.

The HeartLight system is a wireless optical sensor within a custom newborn hat to allow quick and accurate HR monitoring. It will be compared to ECG, PO and electronic stethoscope to determine the accuracy and reliability. The trial has 4 phases; Phase 1 evaluates the thermal properties of the hat, Phase 2 evaluates the accuracy and reliability of the HeartLight sensor on babies within the Neonatal Intensive Care Unit environment, Phase 3 evaluates the HeartLight sensor in newborn babies born by cesarean section and Phase 4 evaluates the performance of the HeartLight sensor in babies of all gestations requiring resuscitation and stabilisation at birth.

The investigators anticipate the HeartLight sensor and hat will allow swift and effective deployment, reduce delays in resuscitation (due to using a stethoscope) and improve HR accuracy (as a result of avoiding errors in the usual manual mental calculations made in the stressful environment of the delivery room) when it is needed most. However, an additional benefit is that it will not require significant modification to the existing care pathway or resuscitation protocols, and therefore a potential barrier to clinical uptake is removed.

02

Conditions studied

  • Infant, Newborn, Diseases
  • Fetus or Neonate Affected by Cesarean Section
  • Infant, Premature, Diseases

Keywords

  • Premature Birth
  • Infant
  • Heart rate
03

In context

Infant, Newborn, Diseases

134 studies on the registry are indexed under Infant, Newborn, Diseases; 30 are open to participants now.

This study's enrollment of 184 is above the median of 114 across 50 observational studies indexed under Infant, Newborn, Diseases.

Browse Infant, Newborn, Diseases studies →

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 4 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Infants

Inclusion criteria

  • Written consent from the mother
  • Realistic prospect of survival as determined by the attending clinical team

Phase 1:

  • Infants on NICU

Phase 2:

  • Infants on NICU requiring heart rate monitoring

Phase 3:

  • Newborn infants following non-emergency elective cesarean section

Phase 4:

  • Newborn infants who attending clinical team anticipate will require assessment of heart rate at time of birth

Feedback:

  • Mothers of babies recruited into HeartLight study
  • Healthcare professionals exposed to the new device

Exclusion criteria

Exclusion Criteria:

Phase 1+2:

  • Infants undergoing palliative care
  • Infants too sick to tolerate additional procedures

Phase 3:

  • Abnormal antenatal scans suggesting significant fetal abnormality (by definition these are not routine pregnancies).
  • Any infant in whom resuscitation is likely to be required.
  • If multiple births then only the first baby born shall be recruited (due to resource limitations with researchers attending the birth)

Phase 4:

  • Infants \<23 weeks
  • Infants that are not for active resuscitation as decided by the clinical team
  • If multiple births then only the first baby born shall be recruited (due to resource limitations with researchers attending the birth)

Feedback:

Unable to obtain written informed consent

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
184 participants (actual)
Patient registry
No

Groups and cohorts

  • NICU infants and hat

    Newborn infants of any gestation on the neonatal intensive care unit (NICU).

    Device: HeartLight hat · Device: The HeartLight hat with in-built sensor

  • NICU infants and sensor

    Newborn infants of any gestation requiring heart rate monitoring on the neonatal intensive care unit.

    Device: The HeartLight hat with in-built sensor · Device: HeartLight · Device: HeartLight device

  • Newborns and surgical delivery

    Well term newborn infants following birth by cesarean section.

    Device: The HeartLight hat with in-built sensor · Device: HeartLight · Device: HeartLight device

  • Newborns needing stabilisation

    Newborn infants requiring resuscitation or stabilisation following birth.

    Device: HeartLight · Device: HeartLight device

  • Parental feedback

    Parental feedback of babies recruited into HeartLight will be sought.

    Other: parental feedback

  • Healthcare provider feedback

    Healthcare professionals caring for babies recruited into HeartLight will have their feedback on the device sought.

    Other: healthcare provider feedback

Interventions

  • DeviceHeartLight hat

    HeartLight hat will be worn for up to 1 hour.

  • DeviceThe HeartLight hat with in-built sensor

    The HeartLight hat with in-built sensor will be worn.

  • DeviceHeartLight

    Electronic stethoscope will be used to estimate heart rate with HeartLight sensor/hat

  • DeviceHeartLight device

    HeartLight sensor/hat will be used with ECG/Pulse oximetry/electronic stethoscope

  • Otherparental feedback

    Questionnaire

  • Otherhealthcare provider feedback

    Questionnaire

06

What researchers measure

Primary outcomes

  1. Heart Rate acquisition time in the first minute of life

    Time to acquire heart rate from new optical hat sensor from birth should be within 1 minute of birth.

    Time frame: 1 hour

Secondary outcomes

  1. Reliability of heart rate generated by HeartLight device

    Assess the reliability of the new heart rate device

    Time frame: 1 hour

  2. Accuracy of heart rate generated by HeartLight device

    Assess the accuracy of the new heart rate device

    Time frame: 1 hour

  3. Feedback on acceptability of hat and device

    Feedback will be recorded via a questionnaire from both healthcare professionals and mothers.

    Time frame: 1 hour

  4. Thermal imaging to determine heat loss whilst wearing hat

    Participants will be thermal imaged whilst wearing the hat to determine heat loss.

    Time frame: 1 hour

  5. Thermal imaging to determine heat loss during stabilisation and/or resuscitation

    Participants will be thermal imaged during stabilisation and/or resuscitation whilst wearing the hat to determine heat loss.

    Time frame: 1 hour

07

Study locations

1 site
  • University of Nottingham NHS Trust
    Nottingham, NG72UH, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02701920
Lead sponsor
University of Nottingham
Collaborators
Heartlight Systems Limited
Responsible party
Sponsor
First posted
Mar 8, 2016
Start date
Mar 2016
Primary completion
Apr 2018
Completion
May 11, 2018
Last update
May 17, 2018

Study contacts

Don Sharkey, PhD
principal investigator · University of Nottingham

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion